TNS Healthcare Introduces DetailMed™: The First Continuous, Consistent, Measure of Call Effectiveness across Countries, Competitors, Brands and Categories

Email this to a friend

03.04.2008 United States

New York

NEW YORK, NEW YORK, April 3, 2008— TNS Healthcare has introduced DetailMed™

A new call assessment tool that provides a consistent measure of detail effectiveness across countries, brand and categories. Tracked continuously via Internet, DetailMed lets pharmaceutical and biotech companies monitor the quality of their own and competitive sales calls, from multi-country to sub-national levels. It currently covers the US and major European markets, and TNS is exploring expansion into Asia-Pacific and Latin America.

Download PDF to view full article

© 1998-2008 Taylor Nelson Sofres plc. All rights reserved. Registered office: TNS House, Westgate, London W5 1UA.
Registered in England and Wales number 912624

Site by TH_NK